96 related articles for article (PubMed ID: 2233918)
1. Altered expression of the retinoblastoma gene product in human sarcomas.
Cance WG; Brennan MF; Dudas ME; Huang CM; Cordon-Cardo C
N Engl J Med; 1990 Nov; 323(21):1457-62. PubMed ID: 2233918
[TBL] [Abstract][Full Text] [Related]
2. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
[TBL] [Abstract][Full Text] [Related]
3. Studies of the retinoblastoma gene in human sarcomas.
Reissmann PT; Simon MA; Lee WH; Slamon DJ
Oncogene; 1989 Jul; 4(7):839-43. PubMed ID: 2755701
[TBL] [Abstract][Full Text] [Related]
4. Expression of the retinoblastoma gene product in renal tumors.
Presti JC; Reuter VE; Cordon-Cardo C; Motzer RJ; Albino AP; Jhanwar SC; Nanus DM
Anticancer Res; 1996; 16(2):549-56. PubMed ID: 8687097
[TBL] [Abstract][Full Text] [Related]
5. Altered retinoblastoma and p53 protein status in non-small cell carcinoma of the lung: potential synergistic effects on prognosis.
Xu HJ; Cagle PT; Hu SX; Li J; Benedict WF
Clin Cancer Res; 1996 Jul; 2(7):1169-76. PubMed ID: 9816284
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group.
Reissmann PT; Koga H; Takahashi R; Figlin RA; Holmes EC; Piantadosi S; Cordon-Cardo C; Slamon DJ
Oncogene; 1993 Jul; 8(7):1913-9. PubMed ID: 8390038
[TBL] [Abstract][Full Text] [Related]
7. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities in structure and expression of the retinoblastoma gene in small cell lung cancer cell lines and xenografts in nude mice.
Rygaard K; Sorenson GD; Pettengill OS; Cate CC; Spang-Thomsen M
Cancer Res; 1990 Sep; 50(17):5312-7. PubMed ID: 2167152
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer.
Cordon-Cardo C; Wartinger D; Petrylak D; Dalbagni G; Fair WR; Fuks Z; Reuter VE
J Natl Cancer Inst; 1992 Aug; 84(16):1251-6. PubMed ID: 1640484
[TBL] [Abstract][Full Text] [Related]
10. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
Tzai TS; Tsai YS; Chow NH
Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
[TBL] [Abstract][Full Text] [Related]
11. Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas.
Xu HJ; Hu SX; Cagle PT; Moore GE; Benedict WF
Cancer Res; 1991 May; 51(10):2735-9. PubMed ID: 1850661
[TBL] [Abstract][Full Text] [Related]
12. p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate.
Theodorescu D; Broder SR; Boyd JC; Mills SE; Frierson HF
J Urol; 1997 Jul; 158(1):131-7. PubMed ID: 9186339
[TBL] [Abstract][Full Text] [Related]
13. Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia.
Kornblau SM; Chen N; del Giglio A; O'Brien S; Deisseroth AB
Cancer Res; 1994 Jan; 54(1):242-6. PubMed ID: 8261446
[TBL] [Abstract][Full Text] [Related]
14. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma.
Cryns VL; Thor A; Xu HJ; Hu SX; Wierman ME; Vickery AL; Benedict WF; Arnold A
N Engl J Med; 1994 Mar; 330(11):757-61. PubMed ID: 7906387
[TBL] [Abstract][Full Text] [Related]
15. Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung.
Dosaka-Akita H; Cagle PT; Hiroumi H; Fujita M; Yamashita M; Sharma A; Kawakami Y; Benedict WF
Cancer; 2000 Feb; 88(3):550-6. PubMed ID: 10649246
[TBL] [Abstract][Full Text] [Related]
16. Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study.
Kornblau SM; Andreeff M; Hu SX; Xu HJ; Patel S; Theriault A; Koller C; Kantarjian H; Estey E; Deisseroth AB; Benedict WF
Clin Cancer Res; 1998 Aug; 4(8):1955-63. PubMed ID: 9717825
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of c-fos induces expression of the retinoblastoma tumor suppressor gene Rb in transfected cells.
Pai SR; Bird RC
Anticancer Res; 1994; 14(6B):2501-8. PubMed ID: 7872673
[TBL] [Abstract][Full Text] [Related]
18. Mutation spectrum of the retinoblastoma gene in osteosarcomas.
Wadayama B; Toguchida J; Shimizu T; Ishizaki K; Sasaki MS; Kotoura Y; Yamamuro T
Cancer Res; 1994 Jun; 54(11):3042-8. PubMed ID: 8187094
[TBL] [Abstract][Full Text] [Related]
19. Retinoblastoma (Rb) gene product expression in lymphomas. Correlation with Ki67 growth fraction.
Martínez JC; Piris MA; Sánchez-Beato M; Villuendas R; Orradre JL; Algara P; Sánchez-Verde L; Martínez P
J Pathol; 1993 Apr; 169(4):405-12. PubMed ID: 8501537
[TBL] [Abstract][Full Text] [Related]
20. Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomas.
Shew JY; Ling N; Yang XM; Fodstad O; Lee WH
Oncogene Res; 1989; 4(3):205-14. PubMed ID: 2740144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
